Home›Stock Screener›Transchem›Financial Statements

Transchem Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Transchem (TRANSCHEM) reported revenue ₹0 Cr, net profit ₹4 Cr and EPS ₹3.51 and ROE of 5.1%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore TRANSCHEM Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Return on Assets 5.00% 2026 data
Return on Equity 5.06% 2026 data

Balance Sheet Ratios

Equity Ratio 98.75% 2026 data

TRANSCHEM Revenue, Net Profit & EBITDA — Year-on-Year Growth

TRANSCHEM YoY (March 2025 vs March 2026) — revenue -100.0%, net profit -20.0%, EBITDA -157.1%. Review TRANSCHEM P/E comparison to evaluate earnings-based valuation against sector peers.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-20.0%
Year-over-Year
EBITDA Growth
-157.1%
Year-over-Year
Assets Growth
+5.3%
Year-over-Year
Equity Growth
+3.9%
Year-over-Year
Operating Cash Flow Growth
+192.3%
Year-over-Year
Investing Cash Flow Growth
+20.0%
Year-over-Year

TRANSCHEM Income Statement — Revenue, EBITDA & Net Profit

Transchem revenue ₹0 Cr, EBITDA ₹-4 Cr, net profit ₹4 Cr, EPS ₹3.51 (2026). For live price, earnings ratios and company overview, see Transchem share price screener.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 0 11 8 4 7 27 3 3 2 2 2 2
Expenses 4 4 2 2 3 2 1 1 2 1 1 1
EBITDA -4 7 6 3 4 25 1 2 0 1 1 1
Operating Profit Margin % 0.00% -56.00% -423.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 6 7 6 3 4 25 1 1 -1 0 0 0
Tax 2 2 1 1 1 1 0 1 1 0 0 0
Net Profit 4 5 4 1 3 24 0 0 -1 0 0 0
Earnings Per Share (₹) 3.51 4.27 3.43 1.01 2.34 19.73 0.33 0.25 -0.97 -0.18 0.04 0.10

TRANSCHEM Balance Sheet — Assets, Liabilities & Shareholders' Equity

TRANSCHEM total assets ₹80 Cr, total equity ₹79 Cr, total liabilities ₹ Cr (2025) — ROE 5.1%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 80 76 66 67 63 37 38 37 38 39 39
Current Assets 78 67 58 58 55 30 28 30 29 28 27
Fixed Assets 0 0 0 0 0 4 4 5 6 7 8
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 2 9 8 9 9 4 6 10 30 26 26
Other Assets 78 67 58 58 55 30 28 21 2 5 5
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 79 76 66 66 63 37 38 37 38 38 38
Share Capital 12 12 12 12 12 12 12 12 12 12 12
Reserves & Surplus 67 63 54 54 51 25 26 25 26 26 26

TRANSCHEM Cash Flow Statement — Operating, Investing & Financing

Transchem operating cash flow ₹36 Cr, investing ₹6 Cr, financing ₹0 Cr, net cash flow ₹42 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 36 -39 1 22 -28 -1 10 -20 1 1 1
Investing Activities 6 5 -1 1 23 1 6 20 -2 0 -1
Financing Activities 0 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 42 -34 0 23 -5 0 16 0 -1 1 0